FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes antibacterial agent that comprises moxifloxacin as a medicinal substance immobilized on polymeric carrier. As a polymer carrier the agent comprises nanoparticles of size 100-800 nm of lactic acid polymer/polymers and/or copolymer/copolymers of lactic acid and glycolic acid wherein the content of glycolic acid in indicated polymers is up to 50 mole% and wherein molecular mass of indicated polymers and copolymers is from 5 to 300 kDa. Also, agent comprises potassium cholesteryl sulfate or sodium glycocholate and a water-soluble natural or synthetic polymeric stabilizing agent of molecular mass 70 kDa, not above, chosen from group involving polyvinyl alcohol, polyvinylpyrrolidone, poloxamer, poloxamine and serum albumin and a filling agent in the amounts given in the invention claim. Agent can comprise additionally water as a solvent or water-containing mixtures. Invention provides the directed delivery of moxifloxacin to pathology focus and to regulate the rate of its releasing from polymeric matrix that provides reducing used doses of antibiotic, deceasing toxic effects and allows overcoming the resistance of infection pathogens.
EFFECT: improved and valuable properties of agent.
2 cl, 3 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR BACTERIAL INFECTIONS TREATMENT | 2007 |
|
RU2337711C1 |
RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
COMPOSITION FOR TREATMENT OF PULMONARY INFECTION | 2001 |
|
RU2185818C1 |
D-CYCLOSERIN-BASED MEDICATION OF PLOLONGED ACTION WITH DOSED RELEASE IN TARGET ORGANS FOR TREATMENT OF RESISTANT FORMS OF TUBERCULOSIS | 2008 |
|
RU2403041C2 |
ANTIMICROBIAL MEDICINAL AGENT, METHOD OF PRODUCTION OF DIRECTIONAL MEDICINAL AGENT CONTAINIG NANOPARTICLES | 2007 |
|
RU2327459C1 |
MEDICINAL AGENT BASED ON RYBAFUTIN, AGENT OF ANTIMICROBIC ACTION CONTAINING NANOPARTICLES, AND RELATED METHOD OF PRODUCTION | 2007 |
|
RU2327457C1 |
PARENTERAL DRUG PREPARATION OF RIFABUTIN FOR THERAPY OF HUMAN AND ANIMAL INFECTIOUS DISEASES | 2012 |
|
RU2481109C1 |
ANTI-TUMOUR PREPARATION | 2011 |
|
RU2451509C1 |
METHOD OF OBTAINING CAPSULATED FORM OF ANTITUBERCULOSIS MEDICATIONS OF RIFAMPICIN SERIES | 2009 |
|
RU2420287C1 |
D-CYCLOSERINE-BASE DRUG, NANOPARTICLES-CONTAINING PREPARATION OF PROLONGED EFFECT, METHOD FOR ITS PREPARING | 2007 |
|
RU2318513C1 |
Authors
Dates
2007-10-27—Published
2006-03-10—Filed